+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 2
Age: 22Years - 45Years
All Genders
ID00000332

High Dose Nimodipine Pharmacotherapy Adjunct

Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-02-24

N/A

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What this Trial Is About

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

CONDITIONS

Brief Title

High Dose Nimodipine Treatment Adjunct - 1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here